Clinical Trial Update: Clinical Study of Second-line Treatment in Advanced Colorectal Cancer With Chemotherapy With Bevacizumab or Cetuximab [Phase 2]

View source ↗

Summary

This is a Phase 2 clinical trial assessing second-line treatment for metastatic colorectal cancer using chemotherapy with either bevacizumab or cetuximab; the s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Avastin (bevacizumab)
• ERBITUX (cetuximab)

Snippet

Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University | Conditions: Colorectal Cancer Metastatic | Phase 2 | Status: RECRUITING